ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients. Currier JS, Moser C, Eron JJ, Chew KW, et al. J Infect Dis 2023;228.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Currier JS, Moser C, Eron JJ, Chew KW, et al. ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients. J Infect Dis 2023;228.
PMID: 37650231